Boston Scientific Valuation
| B1SX34 Stock | BRL 563.16 0.30 0.05% |
At this time, the firm appears to be fairly valued. Boston Scientific shows a prevailing Real Value of R$551.9 per share. The current price of the firm is R$563.16. Our model approximates the value of Boston Scientific from analyzing the firm fundamentals such as Profit Margin of 0.06 %, return on equity of 0.0407, and Current Valuation of 405.56 B as well as examining its technical indicators and probability of bankruptcy.
Fairly Valued
Today
Please note that Boston Scientific's price fluctuation is very steady at this time. Calculation of the real value of Boston Scientific is based on 3 months time horizon. Increasing Boston Scientific's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Boston Scientific is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Boston Stock. However, Boston Scientific's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 563.16 | Real 551.9 | Hype 563.16 |
The real value of Boston Stock, also known as its intrinsic value, is the underlying worth of Boston Scientific Company, which is reflected in its stock price. It is based on Boston Scientific's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Boston Scientific's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Boston Scientific helps investors to forecast how Boston stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Boston Scientific more accurately as focusing exclusively on Boston Scientific's fundamentals will not take into account other important factors: Boston Scientific Total Value Analysis
Boston Scientific is currently projected to have takeover price of 405.56 B with market capitalization of 358.52 B, debt of 8.79 B, and cash on hands of 276 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Boston Scientific fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
405.56 B | 358.52 B | 8.79 B | 276 M |
Boston Scientific Investor Information
The book value of the company was currently reported as 12.32. The company has Price/Earnings To Growth (PEG) ratio of 2.52. Boston Scientific had not issued any dividends in recent years. Based on the measurements of operating efficiency obtained from Boston Scientific's historical financial statements, Boston Scientific is not in a good financial situation at the moment. It has a very high risk of going through financial straits in January.Boston Scientific Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Boston Scientific has an asset utilization ratio of 36.89 percent. This suggests that the Company is making R$0.37 for each dollar of assets. An increasing asset utilization means that Boston Scientific is more efficient with each dollar of assets it utilizes for everyday operations.Boston Scientific Profitability Analysis
The company reported the revenue of 11.89 B. Net Income was 1.04 B with profit before overhead, payroll, taxes, and interest of 8.84 B.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Boston Scientific's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Boston Scientific and how it compares across the competition.
About Boston Scientific Valuation
The stock valuation mechanism determines Boston Scientific's current worth on a weekly basis. Our valuation model uses a comparative analysis of Boston Scientific. We calculate exposure to Boston Scientific's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Boston Scientific's related companies.Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts. BOSTON SCIENDRN operates under Medical Devices classification in Brazil and is traded on Sao Paolo Stock Exchange. It employs 41000 people.
8 Steps to conduct Boston Scientific's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Boston Scientific's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Boston Scientific's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Boston Scientific's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Boston Scientific's revenue streams: Identify Boston Scientific's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Boston Scientific's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Boston Scientific's growth potential: Evaluate Boston Scientific's management, business model, and growth potential.
- Determine Boston Scientific's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Boston Scientific's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for Boston Stock analysis
When running Boston Scientific's price analysis, check to measure Boston Scientific's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Boston Scientific is operating at the current time. Most of Boston Scientific's value examination focuses on studying past and present price action to predict the probability of Boston Scientific's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Boston Scientific's price. Additionally, you may evaluate how the addition of Boston Scientific to your portfolios can decrease your overall portfolio volatility.
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |